Welcome to LookChem.com Sign In|Join Free

CAS

  • or
1-cyclopropyl-7-(4-((2,4-dimethoxyphenyl)sulfonyl)piperazin-1-yl)-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1345888-29-0 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 1345888-29-0 Structure
  • Basic information

    1. Product Name: 1-cyclopropyl-7-(4-((2,4-dimethoxyphenyl)sulfonyl)piperazin-1-yl)-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
    2. Synonyms: 1-cyclopropyl-7-(4-((2,4-dimethoxyphenyl)sulfonyl)piperazin-1-yl)-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
    3. CAS NO:1345888-29-0
    4. Molecular Formula:
    5. Molecular Weight: 531.562
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 1345888-29-0.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: N/A
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: 1-cyclopropyl-7-(4-((2,4-dimethoxyphenyl)sulfonyl)piperazin-1-yl)-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid(CAS DataBase Reference)
    10. NIST Chemistry Reference: 1-cyclopropyl-7-(4-((2,4-dimethoxyphenyl)sulfonyl)piperazin-1-yl)-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid(1345888-29-0)
    11. EPA Substance Registry System: 1-cyclopropyl-7-(4-((2,4-dimethoxyphenyl)sulfonyl)piperazin-1-yl)-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid(1345888-29-0)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 1345888-29-0(Hazardous Substances Data)

1345888-29-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1345888-29-0 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,4,5,8,8 and 8 respectively; the second part has 2 digits, 2 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1345888-29:
(9*1)+(8*3)+(7*4)+(6*5)+(5*8)+(4*8)+(3*8)+(2*2)+(1*9)=200
200 % 10 = 0
So 1345888-29-0 is a valid CAS Registry Number.

1345888-29-0Downstream Products

1345888-29-0Relevant articles and documents

Synthesis and potential antitumor activity of 7-(4-substituted piperazin-1-yl)-4-oxoquinolines based on ciprofloxacin and norfloxacin scaffolds: in silico studies

Abdel-Aziz, Alaa A.-M.,El-Azab, Adel S.,Alanazi, Amer M.,Asiri, Yousif A.,Al-Suwaidan, Ibrahim A.,Maarouf, Azza R.,Ayyad, Rezk R.,Shawer, Taghreed Z.

, p. 796 - 809 (2016/07/07)

The potential antitumor activities of a series of 7-(4-substituted piperazin-1-yl)fluoroquinolone derivatives (1–14a,b) using ciprofloxacin and norfloxacin as scaffolds are described. These compounds exhibit potent and broad spectrum antitumor activities using 60 human cell lines in addition to the inherent antibacterial activity. Compounds 1a, 2a, 3b, 6b and 7a were found to be the most potent, while 2b, 5b, and 6a were found to have an average activity. The results of this study demonstrated that compounds 1a, 2a, 3b, 6b and 7a (mean GI50; 2.63–3.09 μM) are nearly 7-fold more potent compared with the positive control 5-fluorouracil (mean GI50; 22.60 μM). More interestingly, compounds 1a, 2a, 3b, 6b and 7a have an almost antitumor activity similar to gefitinib (mean GI50; 3.24 μM) and are nearly 2-fold more potent compared to erlotinib (mean GI50; 7.29 μM). In silico study and ADME-Tox prediction methodology were used to study the antitumor activity of the most active compounds and to identify the structural features required for antitumor activity.

Design, synthesis and antibacterial activity of fluoroquinolones containing bulky arenesulfonyl fragment: 2D-QSAR and docking study

Abdel-Aziz, Alaa A.-M.,Asiri, Yousif A.,Al-Agamy, Mohamed H.M.

experimental part, p. 5487 - 5497 (2011/12/14)

Here in, we report the design, synthesis, and antibacterial activity of series of bulky arenesulfonamido derivatives using ciprofloxacin and norfloxacin as scaffolds. All the synthesized compounds were investigated in vitro for their antibacterial activit

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1345888-29-0